The benefits of incorporating digital patient-reported outcomes measurement into cancer treatment featured prominently again at this year’s American Society of Clinical Oncology (ASCO) conference.
The beneficial results from last year’s publication in JAMA by Basch et al. were recapped, specifically that in the study group using digital PROMs alongside usual treatments:
31% reported quality of life benefits at 6 months
there were 7% fewer Emergency Room visits
mean overall survival was 5 months longer (translating to an absolute 5 year survival benefit of 8%)
There was also a discussion about barriers to adoption of PROs in routine practice that centred on the need for cost-effective, specialist digital tools.
Read more about the discussion at the conference here.